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Proteinase-3 mRNA expressed by glomerular epithelial cells have been reported: PR-3 is identical to myeloblastin, a
correlates with crescent formation in Wegener’s granulomatosis. growth-promoting protein from myeloid cells [2], and to
Background. Wegener’s granulomatosis (WG) is character- p29b, an antibiotic protein from neutrophils [3]. Further-ized by systemic vasculitis with crescentic glomerulonephritis
more, PR-3 exerts proteolytic activity against extracellular(CGN) and circulating autoantibodies directed against neutro-
matrix proteins and plays a role in neutrophil-mediatedphil cytoplasmic antigens (ANCA). Proteinase 3 (PR-3), a neu-
tral serine proteinase in neutrophils implicated in the growth endothelial cell damage [4, 5]. In experimental models,
control of myeloid cells, has been identified as the target anti- PR-3 has been shown to cause severe tissue damage [6],
gen for ANCA in WG. Since the kidneys are frequently in- and the cytotoxic effects of PR-3 on endothelial cells arevolved in WG, we studied the in situ expression of PR-3 by
partially mediated by apoptosis [7].renal parenchymal cells.
Wegener’s granulomatosis (WG) is characterized byMethods. We assessed the expression of PR-3 in kidney
biopsies of 15 patients with WG by immunohistochemistry systemic vasculitis with necrotizing granulomatous in-
(IHC) and in situ hybridization (ISH). Normal kidney tissue flammation of the respiratory tract and the kidneys, which
served as the control. are frequently involved as the main target organs [8, 9].Results. We detected PR-3 mRNA and PR-3 protein in distal
Immunofluorescence studies of crescentic glomerulone-tubular epithelial cells (TECs) and glomerular epithelial cells
phritis (CGN) in WG demonstrated a “pauci-immune(GECs) in normal kidney tissue and in CGN. Furthermore, a
strong glomerular PR-3mRNA expression restricted to the site glomerulonephritis,” with no or few deposits of immuno-
of cellular crescents was detected in patients with WG. The globulins and complement along the glomerular base-
analysis of 144 glomeruli with cellular or sclerotic crescents re-
ment membrane [10]. Circulating autoantibodies directedvealed a positive correlation of glomerular PR-3mRNA expres-
against neutrophil cytoplasmic antigens (ANCA), how-sion with the percentage of cellular crescents per glomerulus.
The capability of human TECs and GECs to synthesize PR-3 ever, are specific markers for diagnosis and disease activ-
was confirmed by Northern blot and ISH on cultured cells. ity for systemic vasculitides such as WG [11]. While PR-3
Conclusion. These data provide evidence that nonhemato- has been identified as one of the major target antigens
poetic renal parenchymal cells express PR-3 and that glomeru-
for ANCA [12], its role in the pathogenesis has not yetlar expression of PR-3 is associated with crescent formation in
been established. Based on the relationship between levelsWG. Our findings suggest that renal parenchymal cells may
directly be involved in the pathogenesis of CGN in WG. of ANCA and disease activity in WG, an active role for
ANCA in the pathophysiology of these vasculitides has
been proposed [13]. On the other hand, it has been sug-
Proteinase 3 (PR-3) is one of the neutral serine pro- gested that neutrophil activation and degranulation with
teinases of human polymorphonuclear leukocytes. It was the release of cytotoxic proteases (PR-3) subsequently
found to be a 29 kD glycoprotein of 228 amino acids [1]. results in endothelial cell injury [5].
An increasing number of biological properties of PR-3 Immunohistochemical studies of PR-3 in renal tissue
of patients with WG detected the protein PR-3 in infil-
trating neutrophils, as well as extracellularly in crescenticKey words: rapidly progressive glomerulonephritis, crescent glomeru-
lonephritis, vasculitis, ANCA, kidney parenchymal cells. glomeruli and tubular epithelial cells (TECs), suggesting
that PR-3 released by polymorphonuclear neutrophilsReceived for publication June 25, 1998
(PMN) was taken up by renal parenchymal cells [14].and in revised form December 21, 1999
Accepted for publication January 17, 2000 In contrast, we have previously established that TECs
express both PR-3 protein and mRNA in vitro and thatÓ 2000 by the International Society of Nephrology
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binding of anti–PR-3 antibodies to TECs induces the up- tions were incubated with WGM2 (1:50 diluted) at 48C
overnight, followed by biotinylated antimouse IgG, 1:200regulation of adhesion molecules, suggesting that TECs
take an active part in the pathogenesis of CGN in WG diluted (Dako), for one hour at room temperature.
Tissue sections were then incubated for one hour with[15]. However, PR-3 expression by nonhematopoetic cells
is still controversial [16, 17]. avidin-peroxidase complex (Vector Laboratories) at room
temperature. Peroxidase was developed using 3,39-di-Thus, the purpose of the present study was to deter-
mine (1) whether renal parenchymal cells are capable aminobenzidine (DAB; Vector Laboratories) to produce
a brown color. Tissue sections were counterstained withof PR-3 synthesis, and (2) whether PR-3 expression is
up-regulated in CGN of patients with severe WG. Using hematoxylin. Specificity controls included replacement
of primary Ab with normal mouse IgG or rat sera.an in situ hybridization (ISH) technique and immunohis-
tochemistry (IHC), we detected both PR-3 protein and
Isolation and culture of renal TECs and GECstranscripts in renal parenchymal cells in normal kidney
tissue, indicating that PR-3 expression is not restricted Tubular epithelial cells were isolated from human kid-
ney portions obtained from the normal pole of kidneysto hematopoetic cells. In addition, we established that
the expression of PR-3 mRNA by glomerular epithelial removed for renal carcinoma as previously described
[15]. Briefly, the macroscopically normal tissue was dis-cell (GECs) is strongly associated with the extent of cellu-
lar crescent formation in glomeruli of patients with WG. sected, and the outer medulla was sectioned into pieces
of 1 mm3. The tissue was incubated in Hank’s balanced
salt solution (HBSS; Sigma, St. Louis, MO, USA) con-
METHODS
taining 0.2% collagenase II (Sigma) for one hour at 378C
Renal tissue samples from 15 patients with clini- with gentle shaking and filtered through a 120 mm sieve.
cally active WG, rapidly progressive glomerulonephri- After washing and centrifugation with a Metrizamide
tis (RPGN), and immunohistologically proven pauci- gradient (Nycomed, Oslo, Norway), cells were resus-
immune CGN during the years 1993 to 1995 were chosen pended (M199, 20% FCS, 50 mg/mL heparin, 20 mg/mL
for ISH experiments. The diagnosis of WG was estab- ECGF) and plated on 75 mm3 culture flasks (Greiner,
lished by the presence of classic clinical symptoms and Frickenhausen, Germany). For the isolation of GECs,
histopathological findings [8, 18]. All patients were ANCA glomeruli were isolated from kidney cortex and plated
positive with specificity for PR-3. Biopsies from the nor- onto 10 cm Petri dishes (Greiner). Outgrowing GECs
mal pole of four kidneys removed for renal carcinoma were subcultured as previously described [19].
served as controls.
Identification of TECs and GECs
Renal pathology After the first passage, the cells revealed a homoge-
For immunohistologic studies, formalin-fixed tissue was neous morphology. The epithelial origin of the isolated
embedded in paraffin, and 4 mm sections were stained TECs and GECs was determined by immunohistochemi-
with hematoxylin and eosin (H&E) and evaluated by cal staining using Abs to cytokeratin 8, cytokeratin 18
light microscopy. Crescent formation was classified into (Dianova, Hamburg, Germany). To further determine the
two main types: cellular crescents, which contain cells localization within the nephron TECs derived from (proxi-
with little or no collagen deposition within Bowman’s mal or distal TECs), we used Abs to human milk fat
space, and fibrosclerotic crescents with progressive colla- globulin (HMFG) number 1 and 2 (Immunotech, Ham-
gen deposition. Immunofluorescence analysis was per- burg, Germany), g-glutamyl-transferase (GGT; MoAb
formed using FITC-conjugated monoclonal antibodies 102 D2K1B11; kindly provided by Dr. Sabolovic, Nancy,
against human complement factors C3, C4, C1q, IgG, France), glutathione-s-transferase-a (GST-a), and gluta-
IgM, IgA, and fibrinogen on unfixed sections (Dakopatts, thione-s-transferase-p (GST-p; Biotrin, Dublin, Ireland)
Copenhagen, Denmark). Stained sections were analyzed as previously reported [20–24]. The relative percentage
with a Zeiss Axiophot microscope (Zeiss, Oberkochen, of proximal and distal TECs was determined by fluores-
Germany). cence-activated cell sorting (FACS) using monoclonal
To determine the presence of PR-3 protein, we stained antibody (MoAb) D2K1B11 and Abs to HMFG1, HMFG2
paraffin sections of normal kidney tissue and kidney biop- and GST-a and GST-p. according to standard methods.
sies by the immunoperoxidase method using WGM2, a Fluorescence-activated cell sorter (FACS) analysis was
monoclonal antibody (Ab) to human PR-3 (kindly pro- performed in a FACScan (Becton Dickinson, Mountain
vided by Dr. E. Csernok, Lu¨beck, Germany). After block- View, CA, USA) using forward and orthogonal light
ing endogenous peroxidase activity with 0.6% H2O2 and scatter to select viable cells. Data for 3000 cells were
0.2% sodium azide for 10 minutes and blocking endoge- collected. We identified .98% of isolated GECs as epi-
nous avidin and biotin using an avidin/biotin blocking kit thelial cells and .85% of TECs as distal TECs by FACS
analysis (data not shown).(Vector Laboratories, Burlingame, CA, USA), tissue sec-
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Preparation of single-strand PR-3 RNA probe S35-(NEN DuPont, Boston, MA, USA) or digoxigenin-
UTP (Boehringer Mannheim) [27].To create the PR-3 RNA probe for the ISH, we first
detected PR-3 mRNA in HL-60 cells, a myelo-monocytic In situ hybridization
cell line, and in TECs by reverse transcription-polymerase
In situ hybridization was carried out by adapting achain reaction (RT-PCR) method as recently reported
previously described protocol [28]. RNAse-free slides[15, 16]. Total cellular RNA was isolated from TECs at
were coated with 3-aminopropyl-triethoxysilane. Paraf-passages 3 and 4 using a modified guanidinium thiocya-
fin-embedded sections were deparaffinized, rehydrated,nate method [25]. One microgram of TEC RNA was
treated with proteinase K (1 mg/mL) in 50 mmol/L Tris,subjected to RT using the “random priming” method.
5 mmol/L ethylenediaminetetraacetic acid (EDTA), pHRT reagent mixture consisted of 1 mL 20 mmol/L random
8.0, for 15 minutes and postfixed in 4% paraformaldehyde.hexamer primers, 1 mL dNTP mix (10 mmol/L each), 4 mL
After acetylation (0.1 mol/L triethanolamin, pH 8, 0.25%5 3 reaction mix (final concentration: 50 mmol/L Tris-
acetic anhydride), sections were dehydrated, dried, andHCl, pH 8.3, 75 mmol/L KCl, and 3 mmol/L MgCl2), 0.5 mL
prehybridized (50% formamide, 2% Denhardt’s solution,RNAse inhibitor (50 U/mL), 1 mL M-MLV reverse tran-
150 mg salmon sperm DNA, 0.3 mol/L NaCl, 10 mmol/Lscriptase (recombinant Moloney-murine leukemia virus
Tris-HCl, pH 7.5, 10 mmol/L phosphate buffer, 5 mmol/Lreverse transcriptase, 200 U/mL; Stratagene, Heidelberg,
EDTA, pH 8, and 1 mg/mL tRNA). Hybridization wasGermany) and DEPC-treated water up to 20 mL total
performed at 458C in humid chambers using [S35]-UTPvolume. Five to 10 mL were removed for PCR amplifica-
or Dig-UTP–labeled human PR-3 sense and antisensetion. PCR mixture consisted of buffer, 50 pmol sense
probes (106 cpm/section and 50 ng/section, respectively).and antisense primers, 0.1 mmol/L dinucleotides, and
The hybridization buffer consisted of prehybridization1.25 U Taq polymerase (Stratagene). The 50 mL reac-
buffer with 10% dextrane sulfate and 10 mmol/L dithio-tions were covered with mineral oil and incubated in a
threitol (DTT). Subsequently, the sections were washedPerkin Elmer Cetus thermal cycler using 30 cycles of
several times under stringent conditions [0.2 3 standard
one minute at 958C and two minutes at 728C primer
saline citrate (SSC) at 508C], treated with RNase A (20
annealing temperature and polymerase extension tem-
mg/mL; Behring Diagnostics, Sommerville, NJ, USA),
perature. Ten microliters of each RT-PCR reaction were and dehydrated.
electrophoresed on 1% agarose gels. The following We exposed S35-labeled sections to films (X-OMAT-
primer pairs were used in this study: PR-3 sense, 59 ATC AR; Eastman Kodak, Rochester, NY, USA) at 2708C
GTGGGCGGGCACGAGGCG (at the beginning of overnight. Slides were then coated with emulsion (NTB-2;
exon 2, corresponding to bases 82 to 101 of the cDNA), Eastman Kodak). The exposure time, typically between
and PR-3 antisense, 59 GCGGCCAGGGACGAAAGT one and two weeks, was evaluated based on the signal
GCA (at the end of exon 4, corresponding to bases 553 intensity of the autoradiography film. After development
to 582). To exclude the homology region of 21 bp with and fixation, the sections were stained with Harris’s
normal epithelial cell specific antigen-1 (NES-1), we pre- H&E. The localization of silver grains was visualized
pared a second RNA probe using the same antisense by bright- and dark-field microscopy. Glomerular PR-3
primer and another sense primer at the beginning of mRNA expression was scored semiquantitatively (0 5
exon 3: 59 CCTGGTGAACGTGGTGCTCGG 39. The ,50 grains; 1 5 ,200; 2 5 200 to 400; 3 5 .400 grains/
amplification products were separated in 1.5% agarose glomerulus) by two blinded observers. To compare the
gels. Expected sizes of the fragments were 399 and 346 glomerular PR-3 mRNA expression with morphological
bp, respectively. The cDNA fragments were extracted changes in the glomeruli, we assessed the correlation
and purified from a preparative gel using Wizard PCR of glomerular PR-3 mRNA expression (score) and the
preps DNA purification system (Promega A 7170) and percentage of cellular crescents per glomerulus.
subcloned into the polylinker site of bluescript SK1 After washing under stringent conditions as described
(Stratagene). The identity and the orientation of the previously in this article, nonradioactive ISH sections
cDNA fragments were verified by nucleotide sequencing were blocked with 5% bovine serum albumin (BSA)/
after in vitro transcription with T7 or T3 polymerase phosphate-buffered saline (PBS) before incubation with
(Boehringer Mannheim, Mannheim, Germany) according 1:500 dilution of antidigoxigenin Ab (alkaline phospha-
to standard methods [26]. tase labeled; Boehringer Mannheim). According to the
Radioactive and nonradioactive labeling of single- manufacturer’s instructions, slides were washed (100
stranded riboprobes was performed by linearizing the mmol/L Tris, 50 mmol/L MgCl2, 0.1 mol/L NaCl, pH 9.5),
vector downstream of the inserted cDNA fragment, sub- and incubated with 100 mL/section color solution [100
sequent in vitro transcription using the respective phage mg/mL nitro blue tetrazolium (NBT) solution, 100 mg/mL
polymerase (T7 polymerase for antisense and T3 poly- 5-bromo-4-chloro-3-indolyl-phosphate (BCIP) solution,
100 mg/mL Levamisol] in a humid dark chamber formerase for the sense riboprobe), and providing either
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2 to 24 hours. Color development was monitored and Furthermore, we found a weak signal for PR-3 mRNA
in parietal and visceral GECs (Fig. 1). To ensure thatstopped with TE buffer.
To determine whether GECs expressed PR-3 mRNA, GECs were capable of PR-3 mRNA expression, the sig-
nal was enhanced by using radioactive ISH with a pro-we performed dual-staining experiments using nonradio-
active ISH and an Ab against cytokeratin 8/18 (Becton longed exposure time. After three weeks of exposure,
PR-3 mRNA was clearly detected in GECs, while ISHDickinson). After color development of phosphatase-
labeled antidigoxigenin, Abs sections were incubated with the PR-3 sense control showed an unspecific back-
ground (Fig. 1 E, F). There was only minimal chemogra-with 1:50 diluted FITC-labeled anticytokeratin 8/18 Ab
overnight at 48C. ISH signals and cytokeratin fluores- phy (hybridization signal without the RNA probe). In
addition, we assessed the PR-3 protein expression incence were analyzed in the corresponding glomerulus.
normal kidney tissue by IHC. Interestingly, the PR-3
ISH on cytospins protein expression was similarly restricted to GECs and
TECs (Fig. 2). Thus, we established that in normal kidneyTubular epithelial cells and GECs were grown to con-
fluence. One 3 105 cells per slide (TECs, GECs, and tissue renal epithelial cells expressed both PR-3 mRNA
and protein.HL-60) were spun onto ethanol-cleaned slides coated
with 3-aminopropyl-triethoxysilane at 450 r.p.m. for 10
PR-3 mRNA is expressed by human TECs and GECsminutes. Cytospins were air dried, fixed in 4% paraform-
in vitroaldehyde, and stored in 70% ethanol at 48C until use.
Before acetylation, cytospins were pretreated with 0.25% To confirm the in situ expression of PR-3 mRNA by
TECs and GECs, we isolated human TECs and GECsTriton in PBS. Hybridization, washing, and detection
were performed as described previously in this article. and determined the PR-3 mRNA expression by North-
ern blotting and ISH on cultured cells. Cultured GECs
Northern blot and TECs were characterized by FACS analysis as de-
scribed in the Methods section. Both TECs and GECsWe isolated RNA from cultured TECs, GECs, and
HL-60 cells using RNAzol B (Tel-Test Inc., Friends- expressed PR-3 mRNA by the Northern blot technique
at the expected size (Fig. 3). In addition, ISH on culturedwood, TX, USA), a modification of the guanidium thio-
cyanate-phenol-chloroform method [25]. Total RNA TECs and GECs provided a strong signal for PR-3
mRNA compared with the sense control (Fig. 3). HL-60(20 mg) was electrophoresed through a 1% agarose-form-
aldehyde gel, blotted to nylon membrane, and hybridized cells, a myelo-monocytic cell line, served as positive con-
trol (Fig. 3). Thus, TECs and GECs are capable of dein 50% formamide with DIG-labeled nick-translated
probes at 428C. The PR-3 probe was constructed as de- novo synthesis of PR-3 in vitro.
scribed previously in this article. Hybridized membranes
PR-3 mRNA is overexpressed in biopsies of patientswere washed in 2 3 SSC, 0.1% sodium dodecyl sulfate
with WG(SDS) at room temperature and 0.2 3 SSC, 0.1% SDS
at 608C. Blots were reprobed with b-actin (Pst-1 frag- Since we detected PR-3 mRNA in normal kidney tis-
sue, we investigated the expression of PR-3 mRNA inment of pBA-1) as an internal control for quantity and
integrity of RNA. kidney biopsies in 15 patients with active WG and
RPGN. The patient’s ages ranged from 28 to 77 years
(mean 6 SD, 58 6 14), with a female predominance
RESULTS
(9:6; Table 1). At presentation, serum creatinine was
PR-3 mRNA is expressed by human TECs and GECs elevated in 15 out of 15 patients with a range from 1.5
in vivo to 7.0 mg/dL (mean 6 SD, 3.2 6 1.8 mg/dL; Table 1).
Steroid therapy was started in 4 out of 15 patients threeSince we have previously established that anti–PR-3
Abs can induce adhesion molecules in human TECs de- to five days prior to the biopsy. Two patients had a
relapse three years after the first diagnosis of WG (Table 1).rived from normal kidneys [15], we studied the in situ
expression of PR-3 mRNA in normal kidney biopsies. All patients had a positive anti-PR-3 Ab titer, and all
biopsies revealed a pauci-immune CGN. However, theUsing nonradioactive ISH, including two different RNA
probes to PR-3, we detected PR-3 mRNA in normal histomorphological changes varied widely among the pa-
tients reflecting different stages of disease (Table 1). Thekidney tissue in a distinct pattern (Fig. 1). TECs from
distal tubule origin expressed PR-3 mRNA, whereas majority (70 to 90%) of glomeruli were sclerotic in two
patients, while an early stage of disease (50 to 80% mor-proximal TECs morphologically characterized by a high
brush border were negative (Fig. 1). In addition, we phologically normal glomeruli) was detected in four pa-
tients (Table 1).performed ISH with the PR-3 sense probe as a negative
control, and we observed no binding (Fig. 1). Thus, the We analyzed 185 glomeruli of 15 patients by ISH for
the presence of PR-3 mRNA. Radioactive and nonradio-in situ PR-3 mRNA expression by TECs was specific.
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Fig. 1. Proteinase-3 (PR-3) mRNA is expressed by renal epithelial cells in normal kidney biopsies. The expression of PR-3 mRNA was detected
by nonradioactive and radioactive in situ hybridization (ISH) in normal human kidney biopsies. (A and B) Tubular epithelial cells (TECs) from
distal tubule origin expressed PR-3 mRNA (arrows), whereas proximal TECs were negative (arrowheads; A). In addition, we detected PR-3mRNA
signals in glomerular epithelial cells (GECs) by nonradioactive ISH (C; arrows) and radioactive ISH (E; arrows). Control ISH with the PR-3 sense
probe are shown in D (nonradioactive ISH) and F (radioactive ISH). Representative examples (A, C, E, and F) 3200, (B) 3400, and (D) 3100.
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Fig. 2. PR-3 protein is expressed by tubular (TECs) and glomerular epithelial cells (GECs). Distal TEC express PR-3 (arrowheads) in contrast
to proximal TECs below (A). PR-3 is expressed by GECs (arrows) and distal TECs (arrowheads; B). G, glomerulus. Immunoperoxidase 3800.
Fig. 4. PR-3 mRNA is overexpressed in glomeruli of patients with WG, restricted to the site of cellular crescent formation, and colocalized to
cytokeratin-positive cells and radioactive (A) and nonradioactive (B and D) ISH. Cellular crescents contain large epithelial cells (arrows) and a
small number of neutrophil granulocytes (arrowheads; A). GECs express PR-3 mRNA (B and D), dual staining: nonradioactive ISH (D) and
FITC labeled anticytokeratin 8/18 Abs (E). Predominantly cytokeratin positive cells accumulate in cellular crescents (C). In contrast, cytokeratin
expression in normal glomeruli is restricted to the cells of Bowman’s capsule (insert, C). Diffuse glomerular staining of PR-3 protein, immunoperoxi-
dase (F). A, D, E, F 3400; B, C 3100.
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Fig. 3. PR-3 mRNA is expressed by isolated TECs and GECs in vitro. Cytospins of cultured TECs and GECs hybridized with digoxigenin-labeled
PR-3 riboprobe revealed positive PR-3 mRNA expression in TECs (A) and GECs (B). In comparison, the hybridization with sense PR-3 riboprobe
was negative (C). In addition, Northern blot analysis confirmed PR-3 mRNA expression in TECs and GECs (D). Lane 1, GECs unstimulated;
lane 2, GECs stimulated with tumor necrosis factor-a (30 ng/mL) for 24 hours; lane 3, TECs unstimulated; and lane 4, HL-60 cells.
active ISH experiments revealed a strong PR-3 mRNA a strong expression of the PR-3 protein was detected in
glomeruli of patients with WG (Fig. 4F). However, theexpression in glomeruli of patients with WG (Fig. 4 A,
B, and D). Moreover, we determined by light-field mi- PR-3 immunostaining revealed a more diffuse staining
pattern as compared with the ISH, suggesting that PR-3croscopy that the increased glomerular PR-3 mRNA ex-
pression was restricted to the site of cellular crescents was released by infiltrating cells or epithelial cells (Fig. 4
A, B, D, and F).within Bowman’s space (Fig. 4 A, B, and D). Within
cellular crescents, large epithelial cells comprised the In addition to glomerular PR-3 mRNA expression,
PR-3 mRNA expression was also found in distal TECs.majority of cells, whereas only few (2 to 4) neutrophil
granulocytes could be detected per glomerulus (Fig. 4A). However, there was no difference in the expression pat-
tern or the intensity of tubular PR-3 mRNA expressionImmunostaining for cytokeratin confirmed that predomi-
nantly epithelial (cytokeratin positive) cells accumulated between patients with WG and normal kidney tissue
(data not shown).in cellular crescents (Fig. 4C). Interestingly, in crescentic
glomeruli, cytokeratin expression was no longer re-
Glomerular PR-3 mRNA expression correlates withstricted to the cells of Bowman’s capsule, as observed
crescent formationin normal glomeruli (Fig. 4C, insert). Furthermore, the
majority of glomerular PR-3 mRNA–expressing cells The analysis of the ISH experiments in 144 glomeruli
with cellular or sclerotic crescents revealed that differentwere identified as epithelial cells by dual staining (Figs 4
D, E). In addition, we studied the PR-3 protein expres- stages (cellular or sclerotic crescents) and different levels
of crescent formation within the glomeruli (segmental orsion in the biopsies of the patients with WG by immuno-
staining to assess whether the increase in glomerular PR-3 global) were reflected by distinct expression patterns of
PR-3 mRNA (Fig. 5). In sclerotic glomeruli, for example,mRNA expression was accompanied by an enhanced
PR-3 protein expression. Similar to the ISH experiments, PR-3 mRNA was not expressed (Fig. 5A), whereas cellu-
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Table 1. Clinical and histologic features of patients with Current concepts in understanding ANCA-associated
Wegener’s granulomatosis
pauci-immune GN are based on the theory of “neutro-
Serum phil-mediated tissue injury” [5, 29]. After the activationGlomerulia
creatinine and degranulation of PMN, PR-3 is released and causesPatient Age Gender mg/dL Normal Cellular Sclerotic
severe tissue damage. It is well established that PR-3
1 28 F 3.1 1 7 4
exerts cytotoxic effects in vitro and in vivo [30–32]. In2 35 F 1.5 6 11 10
3 44 F 1.6 0 3 7 addition, recent data demonstrated that PR-3 is localized
4 51 M 2.0 2 3 0 extracellularly in renal tissue in patients with ANCA-
5 53 F 2.3 1 3 1
associated GN, suggesting that the release of PR-3 con-6 54 F 2.3 1 10 0
7 57 M 6.3 0 2 16 tributes to renal injury [33, 34]. However, the source of
8 62 M 1.5 3 22 0 the intrarenal-released PR-3 has not yet been estab-
9 62 M 3.3 0 2 2
lished. Here, we report that transcription of PR-3 oc-10 63 M 1.5 10 5 7
11 66 F 7.0 6 12 0 curred in GECs and increased with the progression of
12 72 M 5.7 3 2 4 crescent formation, suggesting that GECs are the pri-
13 73 F 2.5 6 3 0
mary source of PR-3 released into the glomeruli.14 74 F 3.1 0 4 2
15 77 F 3.9 2 2 0 Glomerular crescent formation is a hallmark of rapidly
progressive GN associated with a poor prognosis [34].aNumber of glomeruli classified as normal, cellular crescent, or sclerotic/biopsy
However, the mechanisms leading to its formation are
still unknown. Moreover, cellular crescents are highly het-
erogeneous, and the composition of cellular crescents has
lar crescents were clearly positive (Fig. 5A). Interest- been a controversial issue [35, 36]. Some studies have dem-
ingly, overexpression of PR-3 mRNA in GECs was nota- onstrated that predominantly GECs proliferate within
ble, even before more prominent morphological changes the cellular crescents, whereas others identified macro-
could be detected in the glomeruli (Fig. 5 D, E). The phages or PMNs as the main component [14, 35, 37]. In
comparison of morphological changes and glomerular the present study, the majority of cells within the cres-
PR-3 mRNA expression revealed a strong positive corre- cents were cytokeratin positive and expressed PR-3
lation of glomerular PR-3 mRNA expression with the mRNA. In contrast, macrophages and PMN, however,
percentage of cellular crescents per glomerulus (Fig. 6). are not capable of expressing PR-3 mRNA [38]. Thus,
However, there was no correlation between serum creat- we suggest that in ANCA-associated pauci-immune GN
inine levels and the extent of PR-3 mRNA expression. the majority of cells within the crescents are proliferating
In addition, since PR-3 expression has previously been epithelial cells expressing PR-3.
found in endothelial cells [16], we evaluated PR-3 Interestingly, the proinflammatory cytokines interleu-
mRNA expression in capillaries and larger extraglomer- kin-1 (IL-1) and tumor necrosis factor-a (TNF-a), which
ular vessels. However, in none of the 15 biopsies could are implicated in crescent formation, also induce PR-3 in
PR-3 mRNA expression in extraglomerular vessels be nonhematopoetic cells [39]. In addition, we could dem-
visualized, whereas ISH on cultured preactivated human onstrate that extracellular matrix, a critical factor in the
umbilical vein endothelial cells revealed the same ex- development of fibrosclerotic glomeruli, is a potent in-
pression pattern as TECs or GECs in vitro (data not ducer of PR-3 in GECs in vitro (manuscript in prepara-
shown). On the other hand, severe vasculitic lesions were tion). Thus, we envision that the up-regulation of PR-3
absent in our biopsy specimens. Similar to the ISH on in GECs by proinflammatory cytokines and/or fibrin de-
normal kidney tissue, the ISH with PR-3 mRNA sense position leads to increased PR-3–mediated renal damage.
probe as a negative control as well as hybridization with- In contrast to recent reports that questioned the ex-
pression of PR-3 by TECs, we detected PR-3 mRNA inout any RNA probe did not show any specific expression
normal TECs in vivo and in vitro [17]. How can we(data not shown).
explain this discrepancy? The present study revealed a
distinct expression pattern of PR-3 mRNA in normal
DISCUSSION kidneys: TECs with a high brush border were negative
In the present study, we established that (1) human for PR-3 mRNA. In addition, we have previously estab-
TECs and GECs express PR-3 mRNA, and (2) glomeru- lished that cultured human TECs derived from distal
lar PR-3 mRNA expression correlates with crescent for- tubule origin express PR-3 at the transcript and protein
mation in rapidly progressive GN of WG. The strong level [15]. Thus, the controversial data of PR-3 expres-
association with disease activity suggests an important sion by human TECs could be based on different sub-
role for the expression of PR-3 by nonhematopoetic re- types of cultured TECs. However, the biological rele-
nal epithelial cells in the development of ANCA-associ- vance of PR-3 expression by TECs in morphologically
normal tissue remains to be answered. The primary func-ated pauci-immune GN.
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Fig. 5. Expression of PR-3 mRNA reflects different stages of crescent formation. Radioactive ISH on biopsies of patients with WG. (A) PR-3
mRNA was expressed in cellular crescents (arrows) but not in sclerotic glomeruli (arrowhead). Segmental (B–E) and global (F) cellular crescent
formation was easily detectable through the expression pattern of PR-3 mRNA (arrows indicate glomeruli). (A–F) Representative examples, 3200.
tion of TECs, the most abundant cell type in the kidney Falk et al were the first to demonstrate that ANCA
can activate neutrophils to produce reactive oxygen spe-cortex is solute and water transport, but increasing evi-
dence supports the concept that TECs act as immune cies and release lysosomal enzymes [44]. Pretreatment
(“priming”) of neutrophils with cytokines like tumor ne-accessory cells since they can be induced to express major
histocompatibility complex II antigens [40] and adhesion crosis factor-a, however, is necessary for the expression
of lysosomal enzymes such as PR-3 in the cell membranemolecules [41] as well as to secrete cytokines [42] and
process potentially immunogenic peptides from blood [45]. Binding of anti–PR-3 Ab to primed neutrophils
results in further activation. In addition, our group re-and the glomerular filtrate [43]. Clearly, further studies
are needed to elucidate the function of PR-3 in TECs cently reported that binding of purified anti–PR-3 Ab
to cultured human TECs led to a marked increase of(proteolytic enzyme, growth-promoting protein, or an-
other as yet unknown function?). adhesion molecule expression, suggesting that PR-3 is
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renal injury. Furthermore, the tissue expression of PR-3
as target for circulating ANCA is not restricted to neu-
trophils, and may therefore also contribute to renal dam-
age in patients with WG via direct interaction with
ANCA. The fact that nonhematopoetic, tissue-derived
cells in the kidney of patients with WG are capable of
expressing PR-3 opens new insights into the pathogene-
sis of kidney destruction in WG.
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formation. PR-3 mRNA expression detected by radioactive ISH was
scored semiquantitatively (0 5 ,50, 1 5 ,200, 2 5 200 to 400, 3 5
.400 grains per glomerulus). The percentage of cellular crescents per APPENDIX
glomerulus reflected the extent of crescent formation. Representative
examples of six glomeruli at each score (1 through 3) were compared Abbreviations used in this article are: ANCA, antineutrophil cyto-
with the extent of crescent formation (r 5 0.87, P , 0.001). plasmic antibodies; CGN crescentic glomerulonephritis; DAB, 3,39-
diaminobenzidine; DTT, dithiotreitol; FACS, fluorescence-activated
cell sorting; GECs, glomerular epithelial cells; GGT, g-glutamyl-trans-
ferase; GST-a, glutathione-s-transferase-a; GST-p, glutathione-s-trans-
translocated to cell surface similar to neutrophils [15]. ferase-p; HBSS, Hank’s balanced salt solution; H&E, hematoxylin and
eosin; HMFG, human milk fat globulin; ISH, in situ hybridization;Similarly, human GECs are activated by anti–PR-3 Ab
IHC, immunohistochemistry; NES-1, normal epithelial cell specific an-(manuscript in preparation). Thus, in ANCA-associated tigen-1; PR-3, proteinase 3; PMN, polymorphonuclear neutrophil;
GN, PR-3 expression by renal epithelial cells may con- RPGN, rapidly progressive glomerulonephritis; RT-PCR, reverse tran-
scription-polymerase chain reaction; TECs tubular epithelial cells; WG,tribute to the disease progress.
Wegener’s granulomatosis.In addition, we could not find any PR-3 mRNA expres-
sion in relationship to vascular cells. This may be due
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